During the past decade, Fondation Ophtalmologique A. de Rothschild conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondation Ophtalmologique A. de Rothschild" #1 sponsor was "Fondation Ophtalmologique Adolphe de Rothschild" with 50 trials, followed by "Centre Hospitalier St Anne" with 2 trials sponsored, "Nantes University Hospital" with 2 trials sponsored, "Centre Hospitalier Universitaire Dijon" with 1 trials sponsored and "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondation Ophtalmologique A. de Rothschild" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Centre Hospitalier Régional et Universitaire de Brest" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator, "Foundation Jacques and Gloria Gossweiler" with 1 trials as a collaborator and "Groupe Hospitalier Universitaire Paris psychiatrie & neurosciences" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Fondation Ophtalmologique A. de Rothschild" are "Magnetic Resonance Imaging" (4 trials), "Prognosis" (3 trials), "Acute Stroke" (2 trials), "Blood Pressure" (2 trials) and "Cerebral Hemorrhage" (2 trials). Many other conditions were trialed in "Fondation Ophtalmologique A. de Rothschild" in a lesser frequency.

Most popular intervention types in "Fondation Ophtalmologique A. de Rothschild" are "Device" (22 trials), "Other" (17 trials), "Drug" (5 trials), "Procedure" (5 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Additional MRI sequences" (2 trials), ""pushed" mono-canaliculonasal intubation" (1 trials), "3D PD T1 MRI sequence" (1 trials), "Alteplase" (1 trials) and "Anti-VEGF injections of bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondation Ophtalmologique A. de Rothschild" are 60 trials for "All" genders.

Currently, there are NaN active trials in "Fondation Ophtalmologique A. de Rothschild". 1 are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Fondation Ophtalmologique A. de Rothschild, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Fondation Ophtalmologique A. de Rothschild, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 20 trials that are defined as “Not Applicable".